Valo Therapeutics Company

Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.

Last Funding Type: Debt Financing
Funding Status: Seed
Headquarters: Helsinki, Southern Finland, Finland
Founded Date: 2016-01-01
Last Funding Date: 2020-02-06
Total Funding: 9207932
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Investors Number: 1
Industry: Viral Vectors